CIM

Monday, December 23, 2024

NEWS

Cuba: CITMA awards CIM for effective monoclonal antibody Nimotuzumab

Published on: January 11, 2023
14:44

Havana, Jan 11 (Prensa Latina) The Science, Technology and Environment Ministry (CITMA) awarded Cuba's Center for Molecular Immunology (CIM) for research on the humanized monoclonal antibody Nimotuzumab.

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

Radio – Publications – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado, Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division Prensa Latina.

CIM

Cuba: CITMA awards CIM for effective monoclonal antibody Nimotuzumab

LATEST NEWS